Literature DB >> 11133116

Setting of a colorimetric method to determine the viability of Trypanosoma cruzi epimastigotes.

S Muelas-Serrano1, J J Nogal-Ruiz, A Gómez-Barrio.   

Abstract

The method most commonly used in screening of drugs for the treatment of Chagas' disease, microscopic counting of viable trypanosomes, is time-consuming, labor-intensive, and dependent on the observer. Although the tetrazolium dye [MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is comparatively quick and accurate, it requires careful attention in design as well as in interpretation of the results. Therefore, we examined under various conditions the sensitivity and specificity of the MTT assay versus microscopic counting for determination of the viability of Trypanosoma cruzi for drug-screening purposes. We tested different concentrations of MTT in phenazine methosulfate (PMS) against T. cruzi epimastigotes of the Y strain in different stages of logarithmic growth. In our model, in tests of benznidazole and nifurtimox the optimal concentration of MTT was 2.5 mg/ml of PMS and the optimal incubation period was 75 min. This method detected parasite concentrations of approx. 500,000 epimastigotes/ml (P<0.01), and the linear correlation between absorbance values and numbers of epimastigotes per milliliter was very strong (approx. R = 0.99). The present MTT assay results in faster determination of the activity of compounds, is more objective, and enables testing of several drugs simultaneously.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11133116     DOI: 10.1007/pl00008532

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  26 in total

1.  Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi.

Authors:  Mario Faundez; Laura Pino; Paula Letelier; Carla Ortiz; Rodrigo López; Claudia Seguel; Jorge Ferreira; Mario Pavani; Antonio Morello; Juan Diego Maya
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.

Authors:  Alisson L Matsuo; Luis S Silva; Ana C Torrecilhas; Bruno S Pascoalino; Thiago C Ramos; Elaine G Rodrigues; Sergio Schenkman; Antonio C F Caires; Luiz R Travassos
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

3.  Methodological advances in drug discovery for Chagas disease.

Authors:  Juan M Bustamante; Rick L Tarleton
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

Review 4.  Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.

Authors:  Cristina Fonseca-Berzal; Vicente J Arán; José A Escario; Alicia Gómez-Barrio
Journal:  Parasitol Res       Date:  2018-09-19       Impact factor: 2.289

5.  Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes.

Authors:  Miriam Rolón; Celeste Vega; José A Escario; Alicia Gómez-Barrio
Journal:  Parasitol Res       Date:  2006-02-28       Impact factor: 2.289

6.  Trypanocidal activity and acute toxicity assessment of triterpene acids.

Authors:  Daniele da Silva Ferreira; Viviane Rodrigues Esperandim; Miriam Paula Alonso Toldo; Juliana Saraiva; Wilson Roberto Cunha; Sérgio de Albuquerque
Journal:  Parasitol Res       Date:  2010-02-06       Impact factor: 2.289

7.  Synthesis and characterization of antigenic influenza A M2e protein peptide-poly(acrylic) acid bioconjugate and determination of toxicity in vitro.

Authors:  Yasemin Budama Kilinc; Zeynep Mustafaeva Akdeste; Rabia Cakir Koc; Melahat Bagirova; Adil Allahverdiyev
Journal:  Bioengineered       Date:  2014-11-11       Impact factor: 3.269

8.  In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds.

Authors:  Adriana M C Canavaci; Juan M Bustamante; Angel M Padilla; Cecilia M Perez Brandan; Laura J Simpson; Dan Xu; Courtney L Boehlke; Rick L Tarleton
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

9.  Inhibition of Leishmania mexicana Growth by the Tuberculosis Drug SQ109.

Authors:  Verónica García-García; Eric Oldfield; Gustavo Benaim
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

10.  In vitro and in vivo antileishmanial activities of a Brazilian green propolis extract.

Authors:  Karina Pontin; Ademar A Da Silva Filho; Fransérgio Francisco Santos; Márcio Luís Andrade E Silva; Wilson Roberto Cunha; N P Dhammika Nanayakkara; Jairo Kenupp Bastos; Sérgio de Albuquerque
Journal:  Parasitol Res       Date:  2008-05-20       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.